Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development

Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications

(2021) Donghyun Park et al.   NEUROPHARMACOLOGY

Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum

(2021) Connor Moon et al.   MOLECULAR NEUROBIOLOGY

Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study

(2021) Sunyoung Kang et al.   Scientific Reports

Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends

(2020) Heather L. Girand et al.   PEDIATRICS

Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding

(2020) Khadija Jalloh et al.   LIFE SCIENCES

Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats

(2019) S. H. Lee et al.   Translational Psychiatry

A systematic review of interventions for treatment resistant major depressive disorder in adolescents

(2019) Khrista Boylan et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects

(2019) Leanna Kalinowski et al.   DEVELOPMENTAL PSYCHOBIOLOGY

Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats

(2018) Manoj Kumar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States

(2018) Zhou Zhou et al.   Journal of Attention Disorders

Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period

(2018) Connor Martin et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity

(2018) Sardar M. Z. Uddin et al.   Scientific Reports

Chronic oral methylphenidate treatment increases microglial activation in rats

(2018) Emily Carias et al.   JOURNAL OF NEURAL TRANSMISSION

Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects

(2018) Emily Carias et al.   BEHAVIOURAL BRAIN RESEARCH

Comorbidity of Attention Deficit Hyperactivity Disorder and Generalized Anxiety Disorder in children and adolescents

(2018) M.G. Melegari et al.   PSYCHIATRY RESEARCH

Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats

(2017) Lisa S. Robison et al.   JOURNAL OF NEURAL TRANSMISSION

Preliminary Evidence of an Association Between ADHD Medications and Diminished Bone Health in Children and Adolescents

(2017) Jeffrey T. Howard et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

Prescription stimulant medication misuse: Where are we and where do we go from here?

(2016) Lisa L. Weyandt et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Chondro-protective effects of low intensity pulsed ultrasound

(2016) S.M.Z. Uddin et al.   OSTEOARTHRITIS AND CARTILAGE

Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

(2016) Alexis J. Feuer et al.   JAMA Pediatrics

Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study

(2015) Alexis J. Feuer et al.   BONE

Identification and Characterization of a Synthetic Osteogenic Peptide

(2015) David E. Komatsu et al.   CALCIFIED TISSUE INTERNATIONAL

Establishing Biomechanical Mechanisms in Mouse Models: Practical Guidelines for Systematically Evaluating Phenotypic Changes in the Diaphyses of Long Bones

(2015) Karl J Jepsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: Potential role for 5-HT1B receptor

(2015) Vincent Van Waes et al.   NEUROPHARMACOLOGY

A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior

(2015) Panayotis K. Thanos et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Chronic exposure to methylphenidate impairs appendicular bone quality in young rats

(2012) David E. Komatsu et al.   BONE

Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons

(2012) Vincent Van Waes et al.   JOURNAL OF NEUROCHEMISTRY

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Juvenile Administration of Concomitant Methylphenidate and Fluoxetine Alters Behavioral Reactivity to Reward- and Mood-Related Stimuli and Disrupts Ventral Tegmental Area Gene Expression in Adulthood

(2011) B. L. Warren et al.   JOURNAL OF NEUROSCIENCE

Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity

(2011) Clinton Thomas Elfers et al.   Frontiers in Endocrinology

Antidepressants and Body Weight

(2010) Alessandro Serretti et al.   JOURNAL OF CLINICAL PSYCHIATRY

Modulation of Wnt signaling influences fracture repair

(2010) David E. Komatsu et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing

(2008) Stuart J. Warden et al.   BONE

Longitudinalin VivoAnalysis of the Region-Specific Efficacy of Parathyroid Hormone in a Rat Cortical Defect Model

(2008) David E. Komatsu et al.   ENDOCRINOLOGY